oseltamivir has been researched along with Auricular Fibrillation in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fukushima, T; Goto, A; Izumi-Nakaseko, H; Kambayashi, R; Kawai, S; Matsumoto, A; Onozato, M; Sugiyama, A; Takei, Y | 1 |
Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Kochhäuser, S; Leitz, P; Mittelstedt, A; Wolfes, J | 1 |
Hagiwara, M; Nozaki, S; Sugiyama, A; Suzuki, S; Takahara, A | 1 |
3 other study(ies) available for oseltamivir and Auricular Fibrillation
Article | Year |
---|---|
Simultaneous analyses of hemodynamic and electrophysiological effects of oseltamivir along with its pharmacokinetic profile using the canine paroxysmal atrial fibrillation model.
Topics: Animals; Anti-Arrhythmia Agents; Antiviral Agents; Atrial Fibrillation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Repositioning; Electrophysiological Phenomena; Female; Hemodynamics; Infusions, Intravenous; Oseltamivir | 2022 |
The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antiviral Agents; Atrial Fibrillation; Heart; Humans; In Vitro Techniques; Influenza, Human; Oseltamivir; Rabbits | 2017 |
Electrophysiological effects of an anti-influenza drug oseltamivir on the guinea-pig atrium: comparison with those of pilsicainide.
Topics: Animals; Anti-Arrhythmia Agents; Antiviral Agents; Atrial Fibrillation; Atrial Function; Atrial Function, Left; Atrial Function, Right; Electrophysiological Phenomena; Guinea Pigs; Heart Atria; Humans; Influenza, Human; Lidocaine; Oseltamivir; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sodium Channel Blockers | 2013 |